Hi, what are you looking for?
– Teva sees the court preventing Mylan from launching its generic version of the Parkinson’s treatment before 2017. – Please help us out :...
– The company will use the proceeds to meet increased demand for products, to expand its staff around the world, and to invest heavily...
– The 3D printer company’s secondary offering is an opportunity to look at its remarkable stock market performance, and the people who benefit from...
– N-trig’s multi-touch screen patents have become a critical factor in the smartphone struggle between Apple and Google. – N-trig technology / HTC –...
– New Columbia research reveals that in ALS, communication between cells called astrocytes (pictured) And motor neurons is “profoundly disrupted.” / Photo : Wikipedia...
– The Gaucher and plant-cell treatment developer is offering a convertible note to US financial institutions. – -/ By Nadav Neuman /...
– The Israel Corp’s share price has fallen 61% since Idan Ofer loaned shares to Morgan Stanley three years ago. – – / By...
– Like other Israeli start-ups, the content recommendations company is planning an IPO in 2014. – ...
– Executives of the Italian energy giant told Energy Minister Silvan Shalom that the company wants to enter the Israeli market. – – /By...
– New Pricing is Expected to Add Approximately $7 Million to 2016 EBITDA – – Ormat Technologies, Inc. (NYSE:ORA) announced today that...